The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Medtronic Inc

NYSE: MDT
Last

(U.S.) $73.61

Today's change-0.47 -0.63%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Medtronic Inc

NYSE: MDT
Last

(U.S.) $73.61

Today's change-0.47 -0.63%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Medtronic Inc crosses below 20-day moving average

Medtronic Inc closed lower Friday, dropping (U.S.)$0.47 or 0.63% to (U.S.)$73.61 and crossing below its 20-day moving average. Shares have lost 1.35% over the last five days, but sit 2.71% below their 52-week high. This security has outperformed the S&P 500 by 14.69% during the last year.

Key company metrics

  • Open(U.S.) $74.05
  • Previous close(U.S.) $74.08
  • High(U.S.) $74.22
  • Low(U.S.) $73.51
  • Bid / Ask-- / --
  • YTD % change+28.26%
  • Volume4,206,228
  • Average volume (10-day)7,446,230
  • Average volume (1-month)6,861,332
  • Average volume (3-month)8,697,111
  • 52-week range(U.S.) $53.33 to (U.S.) $75.66
  • Beta1.05
  • Trailing P/E25.41×
  • P/E 1 year forward18.20×
  • Forward PEG2.89×
  • Indicated annual dividend(U.S.) $1.22
  • Dividend yield1.66%
  • Trailing EPS(U.S.) $2.90
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+16.75%

Based on its net profit margin of 16.75%, Medtronic Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 24, 201410/24/2014Jul 25, 201407/25/2014Apr 25, 201404/25/2014Jan 24, 201401/24/2014
Revenue4,3664,2734,5654,163
Total other revenue--------
Total revenue4,3664,2734,5654,163
Gross profit3,2243,1683,3943,113
Total cost of revenue1,1421,1051,1711,050
Total operating expense3,2553,1854,0743,183
Selling / general / administrative1,5071,5061,5391,454
Research & development374365385360
Depreciation / amortization89878689
Interest expense (income), net operating--------
Unusual expense (income)16171834185
Other operating expenses, total-18515945
Operating income1,1111,088491980
Interest income (expense), net non-operating-94-97----
Gain (loss) on sale of assets--------
Other--------
Income before tax1,0221,083481955
Income after tax828871448762
Income tax, total19421233193
Net income828871448762
Total adjustments to net income--------
Net income before extra. items828871448762
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items828871448762
Inc. avail. to common incl. extra. items828871448762
Diluted net income828871448762
Dilution adjustment------0
Diluted weighted average shares9931,0051,0121,010
Diluted EPS excluding extraordinary itemsvalue per share0.830.870.440.75
Dividends per sharevalue per share0.310.310.280.28
Diluted normalized EPSvalue per share0.940.921.210.90